AzTrials
AzTrials

Myopia, High, With Cataract and Anterior Capsule PolishedNCT03142269

The Influences Of Anterior Capsule Polishing On Anterior Capsular Changes and Intraocular Lenses Stability of Super High Myopic Eyes

A study testing 360°anterior capsule polishing in people with Myopia, High, With Cataract and Anterior Capsule Polished, run by yin ying zhao.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective study included 20 patients with super high myopia who underwent bilateral uneventful cataract. 360°anterior capsule polishing was performed with double-ended capsule polisher randomly in one eye, and the opposite unpolished was used as the control. Read more about this study

Who is it for?
Ages 50 to 70 yearsHealthy volunteers can take part
What is being tested?
360°anterior capsule polishing
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
No sites listed yet
Study dates
1 Jan 2015to 31 Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Inclusion Criteria:cataract patients with super high myopia (axial length >27mm) and difference of binocular was less than 1mm Exclusion Criteria:larger corneal astigmatism need toric intraocular lens; patients with any systemic or ocular diseases that may influence the anterior capsule opening morphologic, such as keratonosus, glaucoma, uveitis, Pseudoexfoliation syndrome, retinitis pigmentosa and diabetes and Myotonic Dystrophy, etc.; patients with ophthalmic surgery and trauma history.

About this study

Official title: The Influences of 360° Anterior Capsule Polishing on Refraction, Anterior Capsular Opening Size and IOL Stability Among Super High Myopia Patients

A prospective study included 20 patients with super high myopia who underwent bilateral uneventful cataract. 360°anterior capsule polishing was performed with double-ended capsule polisher randomly in one eye, and the opposite unpolished was used as the control. The refractive state and size of anterior opening were measured at postoperative 1 day as the baseline. Then they followed up at 1 month, 3 months and 6 months after surgery to record refractive state, higher-order aberrations, size of anterior opening, tilt and decentration of IOL (intraocular lenses)and PAD(postoperative aqueous depth). The paired t test was used to compare the differences between the two groups, and the same test the postoperative follow-up comparing with the baseline.

Being tested
360°anterior capsule polishing
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 360°anterior capsule polishingProcedure or surgery

    360°anterior capsule polishing was performed with double-ended capsule polisher

Study groups in NCT03142269
Study groupRoleWhat they receive
polished groupActive comparator360°anterior capsule polishing was performed with double-ended capsule polisher randomly in one eye
Receives: Procedure: 360°anterior capsule polishing
unpolished groupPlacebo comparatorthe opposite unpolished was used as the control
Receives: Procedure: 360°anterior capsule polishing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. refraction

    refractive state

    Measured: Change from postoperative 1 day to 1 months

  2. anterior opening size

    area,diameter

    Measured: Change from postoperative 1 day to 1 months

  3. Stability of IOL

    Tilt and Decentration

    Measured: Change from postoperative 1 months to 3 months

Secondary outcomes (5)
  1. refraction

    refractive state

    Measured: Change from postoperative 1 month to 3 months

  2. refraction

    refractive state

    Measured: Change from postoperative 3 month to 6 months

  3. anterior opening size

    area,diameter

    Measured: Change from postoperative 1 month to 3 months

  4. anterior opening size

    area,diameter

    Measured: Change from postoperative 3 month to 6 months

  5. Stability of IOL

    Tilt and Decentration

    Measured: Change from postoperative 3 month to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2017
  2. Study start1 Jan 2015
  3. Primary completion1 Jul 2015
  4. Study completion31 Jul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03142269
Sponsor's protocol ID
kyk201601
Status last verified
May 2017
First submitted
25 Feb 2017
Last updated
5 May 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing 360°anterior capsule polishing in people with Myopia, High, With Cataract and Anterior Capsule Polished, run by yin ying zhao.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

refraction (time frame: Change from postoperative 1 day to 1 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in